| Old Articles: <Older 43361-43370 Newer> |
|---|
 |
The Motley Fool
August 17, 2010
Brian Orelli |
Forget About This Drug Saving the Company Lilly's Alzheimer's drug fails hard.   |
The Motley Fool
August 17, 2010
Jordan DiPietro |
7 Dirt-Cheap Tech Stocks These highly rated tech stocks are trading at dirt cheap prices. |
The Motley Fool
August 17, 2010
Jeremy Phillips |
Will U.S. Steel Shorts Get Burned? Does this highly shorted stock deserve it? |
The Motley Fool
August 17, 2010
Jordan DiPietro |
Exelon's Dividends May Not Last Forever When we look at Exelon's payout ratio compared with its peer average, we see that it is a lower percentage, which illustrates that its dividend is probably more sustainable. |
The Motley Fool
August 17, 2010
Anders Bylund |
Microsoft Presents: Gaming Phones If you can't beat 'em, try to create a whole new market. |
The Motley Fool
August 17, 2010
Travers & Jayson |
Interested in Cephalon ? Start Here! Every biotech company wants to discover the cure for cancer, Alzheimer's, or Wii knee. Every biotech investor hopes to catch the next Valeant Pharmaceuticals. |
The Motley Fool
August 17, 2010
Jeremy Phillips |
Time to Short Neutral Tandem? Does this highly shorted stock deserve it? |
The Motley Fool
August 17, 2010
Travers & Jayson |
How Long Can Biovail Last? Stop obsessing about the science. |
The Motley Fool
August 17, 2010
Jeremy Phillips |
Time to Short Weyerhaeuser? Does this highly shorted stock deserve it? |
The Motley Fool
August 17, 2010
Jeremy Phillips |
Is FirstEnergy a Short? FirstEnergy is compared to other competitors. |
| <Older 43361-43370 Newer> Return to current articles. |
